Search results
Author(s):
James N Cameron
,
Kadhim I Kadhim
,
Suraya HB Kamsani
,
et al
Added:
11 months ago
Author(s):
Óscar Cano
,
Jeremy P Moore
Added:
8 months ago
Author(s):
David Duncker
,
Gianfranco Mitacchione
Added:
7 months ago
In the latest episode of Arrhythmia Academy's Journal Club, Prof David Duncker (Hannover Heart Rhythm Center, DE) is joined by Dr Gianfranco Mitacchione (University Of Brescia, IT) to discuss leadless pacemakers in patients with chronic kidney disease.Dr Mitacchione provides the current guideline recommendations for leadless pacemakers and presents data from the i-LEAPER (NCT05528029) multi…
View more
Author(s):
Laurent Fiorina
Added:
1 year ago
EHRA 24 - In this short interview, we are joined by Dr Laurent Fiorina (Cardiovascular Institute Paris-Sud (ICPS), FR) joins us to discuss the findings from a clinical investigation into diagnosing conduction tissue disease using an AI-enabled single-lead coronary ECG device.This observational, prospective clinical trial aims to investigate the performance of an artificial intelligence algorithm…
View more
Author(s):
Michal Droppa
,
Tobias Geisler
,
Jan Baan
,
et al
Added:
3 weeks ago
Author(s):
Maarten Antonius Koole
,
Sanne de Jong
,
Barbara J Mulder
,
et al
Added:
1 year ago
Author(s):
Ramón Luengo-Fernández
Added:
1 year ago
ESC 2023 — Dr Ramón Luengo-Fernández (University of Oxford, UK) joins us on-site to discuss the findings from a registry which aimed to analyse the economic burden of cardiovascular disease within the EU.
This was the first study to utilise Europe-wide patient registries and included the costs of long-term social care. Results from the registry found that cardiovascular disease cost the EU €282…
View more
Functional Substrate Mapping
Author(s):
Jaffar Al-Sheikhli
,
Patrick Tran
,
Rafaella Siang
,
et al
Added:
6 months ago
Article
Author(s):
Mads Brix Kronborg
Added:
1 year ago
ESC 2023 — Dr Mads Brix Kronborg (Aarhus University Hospital, DE) joins us to discuss the findings from the DANPACE II Trial (NCT00236158).
DANPACE II (The DANPACE Investigator Group) trial aimed to compare patients who were randomised in a 1:1 ratio to either a base rate of 60 beats per minute and rate-adaptive DDD (DDDR-60 Group) or a base rate of 40bpm and non-rate adaptive DDD (DDD-40…
View more
Peter Lüdike
Job title: Senior Physician
Author